3 Critical Catalysts on the Way for Inovio
Inovio Pharmaceuticals (NASDAQ: INO) tends to stir up strong feelings among investors. Bulls would be quick to point out that the stock is up over 430% so far this year, an impressive gain by any standard. Bears would likely counter that those gains were made in the first half of 2020. Inovio has lost much of its steam in recent months.
Regardless of what you think about Inovio, there's no question that the next few weeks and months will be very important for the biotech stock. Here are three critical catalysts on the way for Inovio.
Image source: Getty Images.
Source Fool.com
